Exane Derivatives’s Americold COLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,956
Closed -$110K 831
2022
Q1
$110K Sell
3,956
-294
-7% -$8.26K 0.03% 460
2021
Q4
$139K Buy
4,250
+1,211
+40% +$37.4K 0.03% 403
2021
Q3
$88.3K Buy
3,039
+2,459
+424% +$90.1K 0.02% 537
2021
Q2
$22.6K Sell
580
-3,256
-85% -$126K 0.01% 693
2021
Q1
$148K Buy
3,836
+3,596
+1,498% +$129K 0.04% 340
2020
Q4
$8.96K Buy
+240
New +$8.63K ﹤0.01% 530
2020
Q3
Sell
-3,477
Closed -$126K 755
2020
Q2
$126K Buy
+3,477
New +$119K 0.03% 262

Other funds holding COLD

Exane Derivatives's COLD Position: Q2 2022 in Review

Exane Derivatives sold out of Americold (COLD) in Q2 2022, closing a stake of 3,956 shares — an estimated $110K sold.

Exane Derivatives first reported a position in COLD in Q2 2020 and held it in 7 quarters. The position peaked at $148K in Q1 2021. 311 funds tracked by Wall St. Rank hold COLD as of Q2 2022.

  • Exane Derivatives reported no remaining Americold position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 3,956 Americold shares in Q2 2022, an estimated $110K.
  • Exane Derivatives first reported a position in Americold in Q2 2020 and held it in 7 quarters.
  • Exane Derivatives's Americold position peaked at $148K in Q1 2021.
  • 311 funds tracked by Wall St. Rank held Americold as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.